Vertaling van "venous thromboembolism " (Frans → Nederlands) :

Risk of venous thromboembolism in users of oral contraceptives
Risk of venous thromboembolism in users of oral contraceptives containing

G. Lowe et P. Sandercock: Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
G. Lowe en P. Sandercock: Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?

(Jick 2006) Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing
(Jick 2006) Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or

(Cole 2007) Cole JA, Norman H, Doherty M, Walker AM. Venous Thromboembolism, Myocardial Infarction, and Stroke Among
(Cole 2007) Cole JA, Norman H, Doherty M, Walker AM. Venous Thromboembolism, Myocardial Infarction, and Stroke Among Transdermal

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone

H. Büller et M. Prins: Secondary prophylaxis with warfarin for venous thromboembolism (editorial).
H. Büller en M. Prins: Secondary prophylaxis with warfarin for venous thromboembolism (editorial).

Prevention and management of venous thromboembolism.
Vicaretti M. Compression therapy for venous disease.

(Vasilakis-Scaramozza 2001) Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or
(Vasilakis-Scaramozza 2001) Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives.

(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral
(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral contraceptives